Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes.
Saved in:
| Title: | Update on Cancer Screening in Children with Syndromes of Bone Lesions, Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome, and Other Rare Syndromes. |
|---|---|
| Authors: | Michaeli O; Division of Hematology and Oncology, Schneider Children's Medical Center of Israel, School of Medicine, Tel Aviv University, Tel Aviv, Israel., Kim SY; Division of Human Genetics, Department of Pediatrics, Cincinnati Children's Hospital, University of Cincinnati, Cincinnati, Ohio., Mitchell SG; Department of Pediatric Hematology and Oncology, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, Georgia., Jongmans MCJ; Department of Genetics, Princess Máxima Center for Pediatric Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Wasserman JD; Division of Endocrinology, Department of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Perrino MR; Department of Oncology, St Jude Children's Research Hospital, Memphis, Tennessee., Das A; Division of Hematology and Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., MacFarland SP; Division of Oncology, The Children's Hospital of Philadelphia, and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Scollon SR; Division of Hematology and Oncology, Department of Pediatrics, Texas Children's Cancer and Hematology Center, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Greer MC; Department of Diagnostic and Interventional Radiology and Department of Medical Imaging, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Sobreira N; McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, Maryland., Gallinger B; Clinical and Metabolic Genetics, The Hospital for Sick Children, Department of Molecular Genetics, The University of Toronto, Toronto, Ontario, Canada., Lupo PJ; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Malkin D; Division of Hematology and Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Schneider KW; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Children's Hospital Colorado, Aurora, Colorado., Schultz KAP; International Pleuropulmonary Blastoma/DICER1 Registry, Cancer and Blood Disorders, Children's Minnesota, Minneapolis, Minnesota., Foulkes WD; Department of Human Genetics, McGill University, Montreal, Quebec, Canada., Woodward ER; Faculty of Biology, Medicine and Health, University of Manchester and Manchester Centre for Genomic Medicine, Manchester, United Kingdom., Stewart DR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Feb 03; Vol. 31 (3), pp. 457-465. |
| Publication Type: | Consensus Statement; Journal Article; Review |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
